J.L. Balibrea
Complutense University of Madrid
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J.L. Balibrea.
Oncology | 1989
M. Díez; M. Arroyo; F.J. Cerdàn; M. Muñoz; M.A. Martin; J.L. Balibrea
Copper, zinc, magnesium, calcium and iron were measured in serum and lung tissue - tumor mass and histologically nonneoplastic tissue - from lung cancer patients and compared with serum concentrations in healthy subjects and control lung tissue obtained from patients with nonmalignant lung disease. Lung cancer patients showed a significant increase in serum Cu and Cu/Zn ratio levels and decrease in serum Zn and Fe concentrations. These findings were correlated with TNM stage of the disease, but not with histologic type of tumor. Malignant lung tissue showed a higher level of Cu, Ca, Mg, and Cu/Zn ratio and lower Zn level than that found in control samples, as well as an increase in Cu, Mg and Cu/Zn ratio concentrations with regard to histologically nonneoplastic tissue samples from the same patient. Tissue concentration of trace metals was not significantly influenced either by histologic type of tumor or clinical TNM stage. Significant correlation coefficients between serum and tissue trace metal levels were not found.
Cancer | 1994
Javier Arias-Díaz; Elena Vara; Juan Torres-Melero; Cruz García; Walid Baki; Juan A. Ramσrez-Armengol; J.L. Balibrea
Background. Cytokines are produced by tumor cells in vitro, but evidence for in vivo increased production of cytokines in cancer patients is controversial. Conversely, nitric oxide (NO) is implicated increasingly in the mediation of cytokine effects.
The Journal of Thoracic and Cardiovascular Surgery | 1998
S. Blanco; Florentino Hernando; Ana Gómez; M.J. González; Antonio J. Torres; J.L. Balibrea
We are grateful to Ms. Chieko Yoshida, Mr. Toshihiko Kanno, Ms. Mieko Kosuga, and Ms. Mutsuko Izumi for their technical assistance. R E F E R E N C E S 1. Jacobson MJ, LoCicero J. Endobronchial treatment of lung carcinoma. Chest 1991;100:837-41. 2. Marasso A, Gallo E, Massaglia GM, Onoscuri M, Bernardi V. Cryosurgery in bronchoscopic treatment of tracheobronchial stenosis. Chest 1993;103:472-4. 3. Petrou M, Goldstraw P. The management of tracheobronchial obstruction: a review of endoscopic technique. Eur J Cardiothorac Surg 1994;8:436-41. 4. Themelin D, Duchatelet P, Boudaka W, Lamy V. Endoscopic resection of an endobronchial hypernephroma metastasis using polypectomy snare. Eur Respir J 1990;3:732-3. 5. Gerasin VA, Shafirovsky BB. Endoscopic electrosurgery. Chest 1988;93:270-4.
Diseases of The Colon & Rectum | 1982
F. Javier Cerdán; Antonio Ruiz de León; Fernando Azpiroz; José Luis Risco Martín; J.L. Balibrea
Resting anal canal pressure was measured in 15 patients with anal fissure before and after lateral internal sphincterotomy. This pressure was found to be significantly higher in these subjects (mean 95±23.08 mm HG) than in the control group (mean 66.10±14.28 mm Hg) before surgery (P<0.005). After surgery, a normal anal canal pressure was produced. The authors maintain that anal canal spasm is responsible for chronicity of anal fissures.
The American Journal of Gastroenterology | 1999
Andrés Sánchez-Pernaute; Florentino Hernando; Luis Díez-Valladares; Oscar Gonzalez; Elia Pérez Aguirre; Vicente Furió; Manuel Remezal; Antonio J. Torres; J.L. Balibrea
We report the case of a 21-yr-old woman who presented with a perforation of an upper esophageal ulcer on a patch of gastric-type mucosa. Despite surgical closure of the perforation and reinforcement with a pleuro-muscular flap the patient developed an esophageal leakage and died in the postoperative period. Heterotopic gastric mucosa in the upper esophagus is usually an asymptomatic abnormality, discovered incidentally during endoscopic studies carried out for some other reason; however, complications secondary to the inlet patch acid secreting capacity can arise, and this has to be kept in mind to elude life-threatening conditions.
Shock | 2000
Javier Arias-Díaz; Ignacio Garcia-Verdugo; Cristina Casals; Natalia Sanchez-Rico; Elena Vara; J.L. Balibrea
Surfactant protein A (SP-A) is thought to play a role in the modulation of lung inflammation during acute respiratory distress syndrome (ARDS). However, SP-A has been reported both to stimulate and to inhibit the proinflammatory activity of pulmonary macrophages (Mphi). Because of the interspecies differences and heterogeneity of Mphi subpopulations used may have influenced previous controversial results, in this study, we investigated the effect of human SP-A on the production of cytokines and other inflammatory mediators by two well-defined subpopulations of human pulmonary Mphi. Surfactant and both alveolar (aMphi) and interstitial (iMphi) macrophages were obtained from multiple organ donor lungs by bronchoalveolar lavage and enzymatic digestion. Donors with either recent history of tobacco smoking, more than 72 h on mechanical ventilation, or any radiological pulmonary infiltrate were discarded. SP-A was purified from isolated surfactant using sequential butanol and octyl glucoside extractions. After 24-h preculture, purified Mphi were cultured for 24 h in the presence or absence of LPS (10 microg/mL), SP-A (50 microg/mL), and combinations. Nitric oxide and carbon monoxide (CO) generation (pmol/microg protein), cell cGMP content (pmol/microg protein), and tumor necrosis factor alpha (TNFalpha), interleukin (IL)-1, and IL-6 release to the medium (pg/microg protein) were determined. SP-A inhibited the lipopolysaccharide (LPS)-induced TNFalpha response of both interstitial and alveolar human Mphi, as well as the IL-1 response in iMphi. The SP-A effect on TNFalpha production could be mediated by a suppression in the LPS-induced increase in intracellular cGMP. In iMphi but not in aMphi, SP-A also inhibited the LPS-induced IL-1 secretion and CO generation. These data lend further credit to a physiological function of SP-A in regulating alveolar host defense and inflammation by suggesting a fundamental role of this apoprotein in limiting excessive proinflammatory cytokine release in pulmonary Mphi during ARDS.
British Journal of Cancer | 1999
E. Adrover; M.L. Maestro; M.T. Sanz-Casla; V del Barco; J Cerdán; Cristina Fernández; J.L. Balibrea
SummaryThe expression of p53 protein was examined in a series of 111 colorectal cancer adenocarcinomas with a long follow-up. A quantitative luminometric immunoassay (LIA) was used for the measurement of wild-type and mutant p53 protein in extracts from colorectal tumour cytosols, p53 being detected in 42% of the samples (range 0.0–52 ng mg–1). Using an arbitrary cut-off value of 2.7 ng mg–1, 25% of the tumours were classified as manifesting high p53 levels. There was no association of p53 expression with patient age, sex, serum preoperative carcinoembryonic antigen (CEA) levels, tumour site and size, nodal status or TNM stage. Significant and independent correlation was found to exist between high p53 levels and prolonged disease-free survival (P = 0.05) at a median follow-up of 60 months. This survival advantage was most apparent among stage III cancer patients. The results from this study would suggest that expression of high p53 levels appear to be useful in selecting a group of colorectal cancer patients with a better prognosis.
Thorax | 1996
J Torres-Melero; J Arias-Diaz; J.L. Balibrea
Pneumomediastinum and subcutaneous emphysema of the neck and thorax can occur exceptionally following a dental procedure. A case is described of acute subcutaneous emphysema of the lateral region of the neck and thorax associated with pneumomediastinum during a dental extraction with an air and water cooled turbine burn drill.
Oncology | 1998
Trinidad Caldés; Pilar Iniesta; Francisco J. Vega; Carmen de Juan; Jose A. Lopez; Eduardo Díaz-Rubio; Cristina Fernández; Javier Cerdán; J.L. Balibrea; Manuel Benito
Immunohistochemical reactivity for p53 protein is common in various human malignancies. Increased intracellular concentration of p53, which is frequently, but not systematically, related to p53 mutation, has been proposed to be associated with poor prognosis in some tumor types. In colorectal cancer, this significance is still a matter of debate. To directly investigate the relationship between prognosis and p53 alterations, we screened a series of 72 colorectal carcinomas for overexpression and mutation of the p53 gene. Mutations in exons 5–9 of the p53 gene were assayed by single-strand conformation polymorphism and direct DNA sequencing, whereas p53 protein accumulation was detected in 10-µm frozen tissue by immunostaining using 2 different monoclonal antibodies (PAb 1801 and DO7). Thirty-six tumors (50%) showed p53 overexpression. Nineteen of the 36 tumors which contained high levels of p53 protein were found to have missense point mutations. Using a multivariate survival analysis, stage, differentiation, p53 immunoreactivity and p53 mutation emerged as risk factors, but only the stage was significant. In univariate analysis, stage, differentiation and p53 immunoreactivity were significant prognostic indicators, while p53 mutation was at the borderline of significance.
Cancer Letters | 1998
Pilar Iniesta; Francisco J. Vega; Trinidad Caldés; Marı́a-José Massa; Carmen de Juan; Francisco J Cerdán; Andrés Sánchez; Jose A. Lopez; Antonio J. Torres; J.L. Balibrea; Manuel Benito
We have studied 61 resected colorectal adenocarcinomas in order to investigate p53 mutations as a prognostic factor for this pathology. Mutations in exons 5-9 of the p53 gene were analyzed by the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) technique followed by sequencing. Our data indicate that p53 exon 7 mutations were prevalent in the latest stages of colorectal carcinogenesis and patients bearing this alteration had the worst prognosis. Therefore, according to our results, mutations affecting exon 7 of the p53 gene could be considered as a useful marker of biological aggressiveness for colorectal cancer.